Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The FDA has issued warning letters to vendors selling injectable BPC-157 as a consumer product
Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: a nationwide, population-based cohort Study
An anticonvulsant that reduces nerve excitability by blocking calcium channels
It sends a message back to your brain and it says, Oh my gosh, we have so much thyroid hormone, lower her TSH
Retatrutide is the first medication to meaningfully address both sides simultaneously, reducing intake while increasing expenditure
Growing desire for more individualized and efficient treatments, rising investment in metabolic medication innovation, and rising obesity incidence worldwide are the main factors propelling the next-generation obesity drug pipeline market's expansion
US$ 21.10
US$ 27.03
US$ 28.92
